PyInvesting

Market research

PHARM.AS Pharming Group N.V

AS EUR Healthcare

Latest close

1.1155 —

As of Nov 19, 2026

Test a moving-average rule with historical data.

Market facts

Market cap
808M
P/E ratio
38.03
Analyst target
2.2437
Dividend yield
Not available
Beta
0.05

Community

Investor discussion

1 comment

Admin profile picture
Admin

Apr 1, 2021

Pharming Group N.V is currently in a long term downtrend where the price is trading 10.7% below its 200 day moving average.

From a valuation standpoint, the stock is 68.0% more expensive than other stocks from the Healthcare sector with a price to sales ratio of 4.5.

Pharming Group N.V's total revenue rose by 1.0% to $46M since the same quarter in the previous year.

Its net income has dropped by 38.6% to $7M since the same quarter in the previous year.

Finally, its free cash flow fell by 5.4% to $16M since the same quarter in the previous year.

Based on the above factors, Pharming Group N.V gets an overall score of 1/5.